high-flow nasal oxygen therapy after esophagectomy for thoracic esophageal cancer

high-flow nasal oxygen therapy after esophagectomy for thoracic esophageal cancer - high-flow nasal oxygen therapy after esophagectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023617

Enrollment

Registered

2016-08-14

Start date

2016-08-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

after esophagectomy for thoracic esophageal cancer

Interventions

high-flow nasal oxygen therapy/ Venturi mask 1 week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who underwent esophagectomy for thoracic esophageal cancer

Exclusion criteria

Exclusion criteria: not intubated patient

Design outcomes

Primary

Measure	Time frame
atelectasis score on chest X-ray, intensive care and hospital length of stay, mortality on Day 28; escalation of respiratory support and patient comfort.	—

Secondary

Measure	Time frame
PaO2/FIO2, intensive care and hospital length of stay, mortality on Day 28; escalation of respiratory support and patient comfort.	—

Countries

Japan

Contacts

Public ContactDaizoh Satoh

Juntendo University School of Medicine Department of Anesthesiology and Pain Medicine

ds0226@fsinet.or.jp080-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026